Camille S. B.
- Country
- France
- Department
- Gastroenterology
Research Overview
- One-Year Real-World Effectiveness of Subcutaneous Guselkumab in Adults with Crohn’s Disease
- Safety and Efficacy of a Stopping Strategy versus Standard Maintenance Dose of JAK Inhibitors in Adults with Deep Remission Ulcerative Colitis (Randomized Controlled Trial)
- Evaluation of Circulating Tumor DNA-Guided Adjuvant Therapy with Fluorouracil, Folinic Acid, and Oxaliplatin in Stage II Colon Carcinoma
Data & Insights
Has run more than one trial at 72 of 156 partner sites.
Specializations
Colorectal Oncology
The investigator specializes in the treatment and management of colon carcinoma, with particular emphasis on early-stage disease intervention and post-surgical care strategies.
- Stage II Colon Cancer Management
- Adjuvant Treatment Protocols
- Disease Surveillance
Clinical interests extend to developing personalized treatment approaches in gastrointestinal oncology.
Molecular Diagnostics
Focused on advancing the application of circulating tumor DNA analysis in clinical practice, particularly for treatment decision-making in oncology.
- Liquid Biopsy Technologies
- Biomarker Analysis
- Molecular Monitoring
Expertise in implementing molecular diagnostic tools for cancer treatment optimization.
Treatment Innovation
Specializes in developing evidence-based approaches for adjuvant chemotherapy administration, with focus on improving disease-free survival outcomes.
- Chemotherapy Protocols
- Treatment Optimization
- Survival Outcomes
Active involvement in advancing therapeutic strategies for early-stage cancer treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.